Chla Dub1 of Chlamydia trachomatis suppresses NF-κB activation and inhibits IκBα ubiquitination and degradation

Cellular Microbiology

Volumn 10, Issue 9, 2008, Pages 1879-1892

  Le Negrate, Gaëlle ^a   Krieg, Andreas ^a   Faustin, Benjamin ^a   Loeffler, Markus ^a   Godzik, Adam ^a   Krajewski, Stan ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN CHLADUB1; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEINASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN SPECIFIC PROTEASE; UBIQUITIN-SPECIFIC PROTEASE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UBIQUITINATION; CELL LINE; CHLAMYDIASIS; DOWN REGULATION; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIOLOGY; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS; CHLAMYDIAE;

BACTERIAL PROTEINS; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DOWN-REGULATION; ENDOPEPTIDASES; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSFECTION; UBIQUITINATION;

EID: 48749090431     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2008.01178.x     Document Type: Article

References (50)

1. Abbott, D.W., Wilkins, A., Asara, J.M., and Cantley, L.C. (2004) The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 14: 2217-2227.
2. Abbott, D.W., Yang, Y., Hutti, J.E., Madhavarapu, S., Kelliher, M.A., and Cantley, L.C. (2007) Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol Cell Biol 27: 6012-6025.
3. Adhikari, A., Xu, M., and Chen, Z.J. (2007) Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26: 3214-3226.
4. Amir, R.E., Iwai, K., and Ciechanover, A. (2002) The NEDD8 pathway is essential for SCF (beta-TrCP)-mediatedubiquitination and processing of the NF-kappa B precursor p105. J Biol Chem 277: 23253-23259.
5. Angot, A., Vergunst, A., Genin, S., and Peeters, N. (2007) Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog 3: E3.
6. Anttila, T., Saikku, P., Koskela, P., Bloigu, A., Dillner, J., Ikaheimo, I., et al. (2001) Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 285: 47-51.
7. Belland, R.J., Zhong, G., Crane, D.D., Hogan, D., Sturdevant, D., Sharma, J., et al. (2003) Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 100: 8478-8483.
8. Ben-Neriah, Y. (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3: 20-26.
9. Bonizzi, G., and Karin, M. (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288.
10. Boyer, L., and Lemichez, E. (2004) Targeting of host-cell ubiquitin and ubiquitin-like pathways by bacterial factors. Nat Rev Microbiol 2: 779-788.
11. Brunham, R.C., and Rey-Ladino, J. (2005) Immunology of Chlamydia infection: Implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5: 149-161.
12. Campbell, S., Richmond, S.J., and Yates, P. (1989) The development of Chlamydia trachomatis inclusions within the host eukaryotic cell during interphase and mitosis. J Gen Microbiol 135: 1153-1165.
13. Chen, Z.J. (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758-765.
14. Chesson, H.W., and Pinkerton, S.D. (2000) Sexually transmitted diseases and the increased risk for HIV transmission: Implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J Acquir Immune Defic Syndr 24: 48-56.
15. Collier-Hyams, L.S., Zeng, H., Sun, J., Tomlinson, A.D., Bao, Z.Q., Chen, H., et al. (2002) Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol 169: 2846-2850.
16. Coope, H.J., Atkinson, P.G., Huhse, B., Belich, M., Janzen, J., Holman, M.J., et al. (2002) CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J 21: 5375-5385.
17. Ea, C.K., Sun, L., Inoue, J., and Chen, Z.J. (2004) TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc Natl Acad Sci USA 101: 15318-15323.
18. Flores, R., Luo, J., Chen, D., Sturgeon, G., Shivshankar, P., Zhong, Y., and Zhong, G. (2007) Characterization of the hypothetical protein Cpn1027, a newly identified inclusion membrane protein unique to Chlamydia pneumoniae. Microbiology 153: 777-786.
19. Hayden, M.S., and Ghosh, S. (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
20. Hoffmann, A., and Baltimore, D. (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210: 171-186.
21. Kattenhorn, L.M., Korbel, G.A., Kessler, B.M., Spooner, E., and Ploegh, H.L. (2005) A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae. Mol Cell 19: 547-557.
22. Kim, D.W., Lenzen, G., Page, A.L., Legrain, P., Sansonetti, P.J., and Parsot, C. (2005) The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci USA 102: 14046-14051.
23. Klemm, S., Gutermuth, J., Hultner, L., Sparwasser, T., Behrendt, H., Peschel, C., et al. (2006) The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. J Exp Med 203: 337-347.
24. Krappmann, D., and Scheidereit, C. (2005) A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways. EMBO Rep 6: 321-326.
25. Lad, S.P., Li, J., da Silva Correia, J., Pan, Q., Gadwal, S., Ulevitch, R.J., and Li, E. (2007a) Cleavage of p65/RelA of the NF-kappaB pathway by Chlamydia. Proc Natl Acad Sci USA 104: 2933-2938.
26. Lad, S.P., Yang, G., Scott, D.A., Wang, G., Nair, P., Mathison, J., et al. (2007b) Chlamydial CT441 is a PDZ domain-containing tail-specific protease that interferes with the NF-kappaB pathway of immune response. J Bacteriol 189: 6619-6625.
27. Laine, A., Topisirovic, I., Zhai, D., Reed, J.C., Borden, K.L., and Ronai, Z. (2006) Regulation of p53 localization and activity by Ubc13. Mol Cell Biol 26: 8901-8913.
28. Le Cam, L., Linares, L.K., Paul, C., Julien, E., Lacroix, M., Hatchi, E., et al. (2006) E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell 127: 775-788.
29. Le Negrate, G., Faustin, B., Welsh, K., Loeffler, M., Krajewska, M., Hasegawa, P., et al. (2008) Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-{kappa}B, suppresses I{kappa}B{alpha} ubiquitination and modulates innate immune responses. J Immunol 180: 5045-5056.
30. Li, H., Kobayashi, M., Blonska, M., You, Y., and Lin, X. (2006) Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem 281: 13636-13643.
31. Li, X., Yang, Y., and Ashwell, J.D. (2002) TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416: 345-347.
32. Meylan, E., Tschopp, J., and Karin, M. (2006) Intracellular pattern recognition receptors in the host response. Nature 442: 39-44.
33. Misaghi, S., Balsara, Z.R., Catic, A., Spooner, E., Ploegh, H.L., and Starnbach, M.N. (2006) Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol 61: 142-150.
34. Mittal, R., Peak-Chew, S.Y., and McMahon, H.T. (2006) Acetylation of MEK2 and I{kappa}B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci USA 103: 18574-18579.
35. Mukherjee, S., Keitany, G., Li, Y., Wang, Y., Ball, H.L., Goldsmith, E.J., and Orth, K. (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211-1214.
36. Mukhopadhyay, D., and Riezman, H. (2007) Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315: 201-205.
37. Munro, P., Flatau, G., and Lemichez, E. (2007) Bacteria and the ubiquitin pathway. Curr Opin Microbiol 10: 39-46.
38. Neish, A.S. (2004) Bacterial inhibition of eukaryotic pro-inflammatory pathways. Immunol Res 29: 175-186.
39. Orth, K., Xu, Z., Mudgett, M.B., Bao, Z.Q., Palmer, L.E., Bliska, J.B., et al. (2000) Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290: 1594-1597.
40. Rosebrock, T.R., Zeng, L., Brady, J.J., Abramovitch, R.B., Xiao, F., and Martin, G.B. (2007) A bacterial E3 ubiquitin ligase targets a host protein kinase to disrupt plant immunity. Nature 448: 370-374.
41. Rowland, S.L., Tremblay, M.M., Ellison, J.M., Stunz, L.L., Bishop, G.A., and Hostager, B.S. (2007) A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling. J Immunol 179: 4645-4653.
42. Ruland, J., Duncan, G.S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., et al. (2001) Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104: 33-42.
43. Schlieker, C., Korbel, G.A., Kattenhorn, L.M., and Ploegh, H.L. (2005) A deubiquitinating activity is conserved in the large tegument protein of the herpesviridae. J Virol 79: 15582-15585.
44. Stehlik, C., Fiorentino, L., Dorfleutner, A., Bruey, J.M., Ariza, E.M., Sagara, J., and Reed, J.C. (2002) The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med 196: 1605-1615.
45. Sweet, C.R., Conlon, J., Golenbock, D.T., Goguen, J., and Silverman, N. (2007) YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Cell Microbiol 9: 2700-2715.
46. Whitcher, J.P., Srinivasan, M., and Upadhyay, M.P. (2001) Corneal blindness: A global perspective. Bull World Health Organ 79: 214-221.
47. Xia, Z.P., and Chen, Z.J. (2005) TRAF2: A double-edged sword? Sci STKE 2005: Pe7.
48. Xiao, W. (2004) Advances in NF-kappaB signaling transduction and transcription. Cell Mol Immunol 1: 425-435.
49. Ye, Z., Petrof, E.O., Boone, D., Claud, E.C., and Sun, J. (2007) Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol 171: 882-892.
50. Zhou, H., Monack, D.M., Kayagaki, N., Wertz, I., Yin, J., Wolf, B., and Dixit, V.M. (2005) Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med 202: 1327-1332.